The FDA warns Novo Nordisk about potentially unreported side effects and deaths from taking Ozempic
Novo Nordisk received a warning letter from the FDA for not reporting all suspected side effects associated with its drug Ozempic, which include two deaths and a suicide incident.
Simona Lipne Warns Those Struggling with Overweight: 'Medication is the Last Thing'
Simona Lipne shares her transformative weight loss journey and emphasizes that medication should be a last resort for those battling obesity.
Mazdutide, the 'miracle' injection to lose up to 15% of weight created by China
A new obesity medication, Mazdutide, developed by China’s Innovent Biologics and Eli Lilly, has shown significant weight loss results and is on track for approval in China.
What do we know about Mazdutide, the medication with which you can lose up to 20 kilograms in a year?
Mazdutide, a weight-loss medication, shows significant weight loss results in a Chinese study, with participants losing an average of nearly 19% of their body weight over 48 weeks.
Secret negotiations could lead to cheaper obesity medicine – and a victory for the government
The Danish government is negotiating with Novo Nordisk to potentially subsidize obesity medication for patients, which could alleviate financial burdens on those with prescriptions.
No to subsidies for obesity medication
The Swedish Dental and Pharmaceutical Benefits Agency has rejected a subsidy application for the obesity medication Wegovy from Novo Nordisk.
New obesity drug dose approved: studies show up to 21 percent weight loss
A new 7.2 mg dose of an obesity medication has been approved, with studies indicating it can lead to significant weight loss in patients.
Obesity medication against alcoholism? New study offers hope
A new study suggests that obesity medications like Mounjaro may effectively reduce alcohol consumption and relapse behaviors in rats and mice.
New concerns about weight loss medications: What happens if they work too well?
Recent trials of a weight loss drug called retatrutide show significant weight loss, raising concerns among researchers about the potential for excessive weight loss and related side effects.
Nurse and husband arrested in the interior of SP with medication banned in Brazil
A nurse and her husband were arrested in Marília, Brazil, for possessing an illegal medication intended for obesity and diabetes control.
Study: This Happened After Stopping Weight Loss Medication
Research indicates that the benefits of the obesity medication tirzepatide fade away after patients discontinue their treatment, with significant weight regain observed in many cases.
The Patents for Weight Loss Drugs Expire: Generics Are Coming
The expiration of patents for weight loss drugs is paving the way for the introduction of generic alternatives in the global obesity medication market.
Obesity drug ignites competition in America
Novo Nordisk has launched its oral weight loss drug 'Wegovy' in the US, leading to intensified competition in the obesity medication market.